In cell culture and animal models of genitourinary cancer, inhibiting MIF activity can reduce the malignant biological behaviors of cancer, such as cell proliferation, angiogenesis, and tumor aggressiveness. This evidence concerns the gene MIF and urogenital neoplasm.